Thomas Stankovich Re Shape Lifesciences Inc. (RSLS) insider trading activity

Thomas Stankovich is Chief Financial Officer of ReShape Lifesciences Inc.. Currently has a direct ownership of 22,777 shares of RSLS, which is worth approximately $130,967. The most recent transaction as insider was on May 31, 2024, when has been sold 48 shares (Common Stock, $0.001 par value per share) at a price of $0.25 per share, resulting in proceeds of $12. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.8K

0% 3M change

0.75% 12M change

Total Value Held $130,967

THOMAS STANKOVICH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2024	SELL Open market or private sale	$12 $0.25 p/Share	48 Reduced 0.21%	22,777 Common Stock, $0.001 p...
Feb 29 2024	SELL Open market or private sale	$7 $0.17 p/Share	43 Reduced 0.19%	22,825 Common Stock, $0.001 p...
Dec 31 2023	SELL Open market or private sale	$10 $0.25 p/Share	42 Reduced 0.18%	22,868 Common Stock, $0.001 p...
Nov 30 2023	SELL Open market or private sale	$8 $0.23 p/Share	39 Reduced 0.17%	22,910 Common Stock, $0.001 p...
Oct 25 2023	SELL Open market or private sale	$35 $0.27 p/Share	131 Reduced 0.57%	22,949 Common Stock, $0.001 p...
Oct 11 2023	SELL Open market or private sale	$36 $0.93 p/Share	39 Reduced 0.17%	23,080 Common Stock, $0.001 p...
Sep 01 2023	SELL Open market or private sale	$105 $0.89 p/Share	118 Reduced 0.51%	23,119 Common Stock, $0.001 p...
Aug 24 2023	SELL Open market or private sale	$55 $1.42 p/Share	39 Reduced 0.17%	23,237 Common Stock, $0.001 p...
Aug 04 2023	SELL Open market or private sale	$154 $1.43 p/Share	108 Reduced 0.46%	23,276 Common Stock, $0.001 p...
Jul 06 2023	SELL Open market or private sale	$155 $1.47 p/Share	106 Reduced 0.45%	23,384 Common Stock, $0.001 p...
Jun 30 2023	BUY Open market or private purchase	$26,907 $1.52 p/Share	17,702 Added 42.97%	23,490 Common Stock, $0.001 p...
May 31 2023	SELL Open market or private sale	$236 $2.41 p/Share	98 Reduced 1.66%	5,788 Common Stock, $0.001 p...
Apr 30 2023	SELL Open market or private sale	$226 $2.36 p/Share	96 Reduced 1.6%	5,886 Common Stock, $0.001 p...
Mar 31 2023	SELL Open market or private sale	$283 $2.6 p/Share	109 Reduced 1.79%	5,982 Common Stock, $0.001 p...
Feb 28 2023	SELL Open market or private sale	$437 $4.25 p/Share	103 Reduced 1.66%	6,091 Common Stock, $0.001 p...
Feb 02 2023	SELL Open market or private sale	$2,086 $13.29 p/Share	157 Reduced 2.47%	6,194 Common Stock, $0.001 p...
Jan 24 2023	SELL Open market or private sale	$1,183 $7.49 p/Share	158 Reduced 2.43%	6,351 Common Stock, $0.001 p...
Dec 01 2022	SELL Open market or private sale	$1,103 $0.15 p/Share	7,357 Reduced 2.21%	325,404 Common Stock, $0.001 p...
Nov 28 2022	SELL Open market or private sale	$62,008 $0.17 p/Share	364,756 Reduced 52.29%	332,761 Common Stock, $0.001 p...
Nov 17 2022	BUY Grant, award, or other acquisition	-	364,756 Added 34.34%	697,517 Common Stock, $0.001 p...
Nov 04 2022	SELL Open market or private sale	$2,266 $0.27 p/Share	8,393 Reduced 2.46%	332,761 Common Stock, $0.001 p...
Oct 04 2022	SELL Open market or private sale	$2,322 $0.28 p/Share	8,293 Reduced 2.39%	338,670 Common Stock, $0.001 p...
Sep 06 2022	SELL Open market or private sale	$1,883 $0.39 p/Share	4,828 Reduced 1.37%	346,963 Common Stock, $0.001 p...
Aug 05 2022	SELL Open market or private sale	$2,222 $0.47 p/Share	4,728 Reduced 1.33%	351,791 Common Stock, $0.001 p...
Jul 01 2022	SELL Open market or private sale	$2,547 $0.55 p/Share	4,630 Reduced 1.28%	356,519 Common Stock, $0.001 p...

Also insider at

RSLS

ReShape Weightloss Inc.

Chief Financial Officer